Homeopathic treatment of pimples

Phase 3

Completed

• Conditions: Acne vulgaris,

• Registration Number: CTRI/2018/11/016248
• Lead Sponsor: National Institute Of Homoeopathy

Brief Summary

Acne is estimated to affect 9.4% of the global population, making it the eighth most prevalent disease worldwide. Acne vulgaris gets itself enlisted with diseases that directly affect quality of life. Several studies showed significant result of homeopathic medicines as compared to the control group. In this prospective, double blind, randomised, placebo controlled, two parallel arms trial at National Institute of Homoeopathy, 126 patients suffering from acne vulgaris will be randomised in 1:1 ratio into either individualised homeopathic medicines or placebo. Global Acne Grading System (GAGS) score will be used as the primary outcome measure and Cardiff Acne Disability Index (CADI) questionnaire and Dermatological Life Quality Index (DLQI) as the secondary outcome measures; measured at baseline, after 12 weeks. At the end of 12 weeks, comparative analysis will be carried out to detect group differences, if any. Results will be published in scientific journals.

Detailed Description

Not available

Study Timeline

• Study Start: 2018-01-11
• Last Update Posted: 2020-09-22

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 126

Inclusion Criteria

• Patients suffering from acne vulgaris 2.
• Both sexes 3.
• Age between 12 and 30 years 4.
• Patients giving written consent to participate 5.
• Literate patients who can read English and/or Bengali.

Exclusion Criteria

• Patients having severe form of acne vulgaris 2.
• Patients using oil based cosmetics for long period of time 3.
• Patients who are too sick for consultation 4.
• Unwilling to take part and not giving consent to join the study 5.
• Unable to read patient information sheet 6.
• Diagnosed cases of unstable mental or psychiatric illness 7.
• Uncontrolled or life threatening illness affecting quality of life or any organ failure 8.
• Pregnancy and lactation 9.
• Substance abuse and/or dependence 10.
• Self-reported immune compromised state 11.
• Undergoing homoeopathic treatment for any chronic disease within last 6 months.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Global Acne Grading System (GAGS) score	At baseline and after 12 weeks

Secondary Outcome Measures

Name	Time	Method
Cardiff Acne Disability Index (CADI)	At baseline and after 12 weeks
Dermatology Life Quality Index (DLQI)	At baseline and after 12 weeks

Trial Locations

Locations (1)

National Institute Of Homoeopathy; 🇮🇳 Kolkata, WEST BENGAL, India

National Institute Of Homoeopathy

🇮🇳Kolkata, WEST BENGAL, India

Shruti Rai

Principal investigator

7565861275

shu28d@gmail.com